Literature DB >> 3058737

Development of a dot enzyme immunoassay for dengue 3: a sensitive method for the detection of antidengue antibodies.

M J Cardosa1, T P Hooi, N S Shaari.   

Abstract

Partially purified DEN3 virus was used as antigen in a sensitive dot enzyme immunoassay (DEIA) for the detection of antibodies to flavivirus antigens. We describe here the method used to prepare and optimise the antigen-bearing nitrocellulose membranes and present the results obtained from screening 20 acute phase sera from patients shown to have had recent dengue infections by the haemagglutination inhibition (HI) test. Sixteen pairs of acute and convalescent sera from dengue-negative patients had no detectable antibody to dengue virus by HI. These were shown to have no antibody detectable by DEIA. Sera positive for dengue antibodies by HI had DEIA titers ranging from 10 to several thousand times greater than the titers detected by HI.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3058737     DOI: 10.1016/0166-0934(88)90090-0

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  4 in total

Review 1.  Current advances in dengue diagnosis.

Authors:  Pei-Yun Shu; Jyh-Hsiung Huang
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

2.  Dot enzyme immunoassay: an alternative diagnostic aid for dengue fever and dengue haemorrhagic fever.

Authors:  M J Cardosa; P H Tio
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

Review 3.  Advances in dengue diagnosis.

Authors:  M G Guzmán; G Kourí
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

4.  Dengue viruses binding proteins from Aedes aegypti and Aedes polynesiensis salivary glands.

Authors:  Van-Mai Cao-Lormeau
Journal:  Virol J       Date:  2009-03-25       Impact factor: 4.099

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.